A delivery system of linezolid to enhance the MRSA osteomyelitis prognosis: in vivo experimental assessment

Abstract : Staphylococcusaureus, a major responsible microorganism of osteomyelitis, represents a challenge to treat because of the poor penetration of antibiotics in bone and increasing minimum inhibitory concentrations (MICs) to glycopeptides. The calcium-deficient apatites (CDA), closer to the biological components found in bone and other calcified tissues, have osteoconductive properties. So, to process severe osseous infections, CDA can be used to deliver in the infectious site antibiotics like linezolid. The acute experimental osteomyelitis due to methicillin-resistant Staphylococcusaureus (MRSA) was induced in rabbit’s femurs and surgery mimicking human procedures was performed at day three after inoculation. Animals were randomly assigned to treatment groups: L(IV)[4-day linezolid IV infusion, human-equivalent dose of 10 mg/kg/12 h], L (CDA50%) (100 mg CDA with linezolid 500 μg/mg) and L (CDA50%) +L (IV). Surviving bacteria were counted in bone marrow (BM) and bone (Bo) at day 3 (before treatment), day 7 (4-day treatment) or day 17 (14-day treatment). L(iv) was effective after a 4-day treatment with a log[10]CFU/g decrease of −2.63±1.92 and −2.17±1.58 in bone marrow and bone, respectively. CDA loaded with linezolid enhance the efficacy of the IV linezolid regimen by more than one log[10]CFU/g.
Complete list of metadatas

Cited literature [10 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-01847872
Contributor : Valérie Pecqueret <>
Submitted on : Tuesday, July 24, 2018 - 10:10:10 AM
Last modification on : Tuesday, April 30, 2019 - 5:26:02 PM
Long-term archiving on : Thursday, October 25, 2018 - 1:58:24 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

A. Gaudin, C. Jacqueline, Hélène Gautier, C. Desessard, V. Le Mabecque, et al.. A delivery system of linezolid to enhance the MRSA osteomyelitis prognosis: in vivo experimental assessment. European Journal of Clinical Microbiology and Infectious Diseases, Springer Verlag, 2013, 32 (2), pp.195 - 198. ⟨10.1007/s10096-012-1731-6⟩. ⟨inserm-01847872⟩

Share

Metrics

Record views

71